# FDA Inspection 1114822 - Octapharma Plasma, Inc. - November 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/97ab5bdd-3bee-4239-afa4-5e3fc9e07d98
Source feed: FDA_Inspections

> FDA Inspection 1114822 for Octapharma Plasma, Inc. on November 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1114822
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2019-11-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1291156 - 2025-12-18](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8d835320-6834-4dd6-9e72-01fe83eaad5d)
- [FDA Inspection 1291156 - 2025-12-18](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1125ceaf-7ff8-48c1-992a-dae0550d1490)
- [FDA Inspection 1003020 - 2017-03-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/20cafcd4-becc-4c59-9627-f155999db1a3)
- [FDA Inspection 798204 - 2012-09-11](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/71b6ba99-0232-4705-8555-28dd6403618b)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/3dd44583-a7e0-49f6-8f18-90a74def14e3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d